Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(1167)
Joseph P. McEvoy
72
Herbert Y. Meltzer
57
James L. Kennedy
56
Diana O. Perkins
52
Robert M. Hamer
49
Journals
(84)
SCHIZOPHR RES
94
BIOL PSYCHIAT
31
Neuropsychopharm...
24
AMER J PSYCHIAT
24
SCHIZOPHRENIA BULL
20
Keywords
(604)
Embed
Subscribe
Academic
Authors
Jeffrey A. Lieberman
Jeffrey A. Lieberman,Columbia University,Psychiatry & Psychology,Pharmacology,Neuroscience
Edit
Jeffrey A. Lieberman
Columbia University
Publications:
401
|
Citations:
12237
Fields:
Psychiatry & Psychology
,
Pharmacology
,
Neuroscience
View FAQ about top research areas and Fields of study
Collaborated with
1167 co-authors
from 1991 to 2011
|
Cited by
23241 authors
Cumulative
Annual
Sort by:
Publications
(401)
BibTeX
|
RIS
|
RefWorks
Download
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
(
Citations: 8
)
D E Adkins
,
K Åberg
,
J L McClay
,
J Bukszár
,
Z Zhao
,
P Jia
,
T S Stroup
,
D Perkins
,
J P McEvoy
,
J A Lieberman
,
P F Sullivan
,
E J C G van den Oord
Journal:
Molecular Psychiatry - MOL PSYCHIATR
, vol. 16, no. 3, pp. 321-332, 2011
Genome-wide association study identifies five new schizophrenia loci
(
Citations: 1
)
Stephan Ripke
,
Alan R Sanders
,
Kenneth S Kendler
,
Douglas F Levinson
,
Pamela Sklar
,
Peter A Holmans
,
Dan-Yu Lin
,
Jubao Duan
,
Roel A Ophoff
,
Ole A Andreassen
,
Edward Scolnick
,
Sven Cichon
Jeffrey A Lieberman
http://academic.research.microsoft.com/io.ashx?type=5&id=56593835&selfId1=641293&selfId2=0&maxNumber=12&query=
Journal:
Nature Genetics - NAT GENET
, vol. 43, no. 10, pp. 969-976, 2011
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
(
Citations: 6
)
J L McClay
,
D E Adkins
,
K Åberg
,
S Stroup
,
D O Perkins
,
V I Vladimirov
,
J A Lieberman
,
P F Sullivan
,
E J C G van den Oord
Journal:
Molecular Psychiatry - MOL PSYCHIATR
, vol. 16, no. 1, pp. 76-85, 2011
Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride
(
Citations: 1
)
Mark Slifstein
,
Raymond F Suckow
,
Jonathan A Javitch
,
Thomas Cooper
,
Jeffrey Lieberman
,
Anissa Abi-Dargham
Journal:
Journal of Cerebral Blood Flow and Metabolism - J CEREBR BLOOD FLOW METABOL
, vol. 31, no. 1, pp. 293-304, 2011
A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia
(
Citations: 6
)
Robert W. Buchanan
,
Richard S. E. Keefe
,
Jeffrey A. Lieberman
,
Deanna M. Barch
,
John G. Csernansky
,
Donald C. Goff
,
James M. Gold
,
Michael F. Green
,
L. Fredrik Jarskog
,
Daniel C. Javitt
,
David Kimhy
,
Michael S. Kraus
http://academic.research.microsoft.com/io.ashx?type=5&id=49286033&selfId1=641293&selfId2=0&maxNumber=12&query=
Journal:
Biological Psychiatry - BIOL PSYCHIAT
, vol. 69, no. 5, pp. 442-449, 2011
Sort by:
Citations
(12237 times by 8018 publications)
Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors
(
Citations: 1
)
Stéphane Potvin
,
Katherine Stavro
,
Julie Pelletier
Journal:
Journal of Dual Diagnosis
, vol. just-accep, no. just-accep, 2012
The Potential Role of Long-Acting Injectable Antipsychotics in People With Schizophrenia and Comorbid Substance Use
(
Citations: 1
)
Maju Mathew Koola
,
Heidi J. Wehring
,
Deanna L. Kelly
Journal:
Journal of Dual Diagnosis
, vol. just-accep, no. just-accep, 2012
Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study
(
Citations: 2
)
A J Risselada
,
J Vehof
,
R Bruggeman
,
B Wilffert
,
D Cohen
,
A F Al Hadithy
,
J Arends
,
H Mulder
Journal:
Pharmacogenomics Journal - PHARMACOGENOMICS J
, vol. 12, no. 1, pp. 62-67, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Yves Agid
,
Martin Brüne
,
Edward T. Bullmore
,
Cameron S. Carter
,
Nicola S. Clayton
,
Richard Connor
,
Sabrina Davis
,
Bill Deakin
,
Robert J. DeRubeis
,
Bruno Dubois
,
Mark A. Geyer
,
Guy M. Goodwin
http://academic.research.microsoft.com/io.ashx?type=5&id=56604824&selfId1=641293&selfId2=0&maxNumber=12&query=
Journal:
Nature Reviews Drug Discovery - NAT REV DRUG DISCOV
, vol. 11, no. 2, pp. 141-168, 2012
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia
G Kirov
,
A J Pocklington
,
P Holmans
,
D Ivanov
,
M Ikeda
,
D Ruderfer
,
J Moran
,
K Chambert
,
D Toncheva
,
L Georgieva
,
D Grozeva
,
M Fjodorova
http://academic.research.microsoft.com/io.ashx?type=5&id=56564762&selfId1=641293&selfId2=0&maxNumber=12&query=
Journal:
Molecular Psychiatry - MOL PSYCHIATR
, vol. 17, no. 2, pp. 142-153, 2012
Comments